“Young And Sexy” free magazine launched to create the right attitude toward birth control pills

Press Releases »

Bangkok--21 Aug--Four Hundred

Bayer Thai Co., Ltd., one of the world's leading, innovative companies in the healthcare and medical products industry, launched “Young And Sexy” magazine to educate women on proper use of birth control pills. The first issue, under the theme of “Birth control pills: For larger breasts and beauty?”, provides the information on health, beauty and leisure. It is now available in leading pharmacies countrywide. Ms. Heike Prinz, General Manager of Bayer HealthCare Pharmaceuticals in Thailand, revealed that “Bayer, as the global leader in Women's Healthcare, is well aware of the current misperception and sometimes improper use of birth control pills, especially among Thai women. That is why the company published “Young And Sexy” magazine to educate women about contraception in general and birth control pill in particular. This magazine will provide modern women with information on contraceptive pills, which could reduce the rate of unwanted pregnancy, to give back to the society and ensure the better life.” This 24x35-cm “Young And Sexy” quarterly magazine is free of charge. The first issue, published for 100,000 provides not only knowledge of birth control pills, but also information on beauty, lifestyle and healthcare. The magazines are available in many pharmacies, starting from Bangkok and surroundings before expanding nationwide,” added Ms. Prinz. Regarding this topic, Prof. Surasak Thaneepanichsakul, M.D., obstetrician and Dean of College of Public Health Science, Chulalongkorn University, said, “Because of current false belief, many women are unhappy with their natural breasts and take contraceptive pills to enlarge the size. In fact, the breast engorgement is only the side effect of estrogen hormone, the pills’ component that causes water retention. Therefore, women thought that the pills enlarge their breasts. Meanwhile taking the pills, women will gain weight, with fat accumulating at some parts like hip, and have rounder face. However, after stopping the medication, the effect gradually weakens. This is the reason for young ladies of using the pills’ side effect to make their breasts bigger.” Prof. Vorapong Poopong, M.D., obstetrician of Chulalongkorn Hospital, talked about other benefits of birth control pills. He revealed, “Currently, the pills are also used for other purposes, such as treating acne and reducing premenstrual dysphoric disorder (PMDD). If any women would like to start using the pills, they should always consult with the doctors or pharmacists for their own safety. Do not trust only friends or commercial ads.” Contact: Chayanan Boonyaperm Tel. +66 2 232 7018 E-mail: [email protected] Sitikorn Sangiamprong Tel. +662-553-3161-3 E-mail: [email protected] For more information, please visit www.bayer.co.th -NT- Click for photo release at www.thaipr.net

ข่าวBayer HealthCare+innovativeวันนี้

Blue Elephant Group Showcases Latest Products THAIFEX-Anuga Asia 2025 at IMPACT Muang Thong Thani

Master Chef Nooror Somany Steppe (4th from left), founder of Blue Elephant Cooking School & Restaurant, unveiled an exciting new range of products at Blue Elephant's spacious and visually immersive booth in Hall 10, Fine Food section, during THAIFEX-Anuga Asia 2025, held recently at IMPACT Muang Thong Thani. The new product highlights included a groundbreaking collection of innovative Thai Curry Powders, a new packaging format for Blue Elephant Thai Premium Curry Sauces, as well as the launch of

SCB Tech X Co., Ltd. (SCB TechX), a strat... SCB TechX Launches OCR Service: AI & LLM-powered Digital Document Conversion — SCB Tech X Co., Ltd. (SCB TechX), a strategic and digital transformatio...

International Federation on Ageing and Bayer HealthCare Release Report Raising Awareness of How Pets Contribute to Healthy Ageing

The first-of-its-kind report investigates how pets may contribute to physical, mental and societal well-being, in an ageing global demographic With advances in global...

TREATMENT OF PRIMARY LIVER CANCER: SARAH STUDY NOW AVAILABLE FOR ALL ELIGIBLE PATIENTS THROUGHOUT FRANCE

Launched by the Assistance Publique Hopitaux de Paris (AP-HP) in December 2011, SARAH, a French national collaborative randomized controlled trial of radioembolization with yttrium-90 resin...

Landmark Phase III Study of Bayer's Xarelto(R) (Rivaroxaban) Initiated for the Secondary Prevention of Myocardial Infarction and Death in Patients with Coronary or Peripheral Artery Disease

Not intended for U.S. and UK Media - 20,000-patient study will be conducted in collaboration with Population...

วันคุมกำเนิดโลก ปี 55 ผลสำรวจชี้ หญิงเอเชียคุมกำเนิดน้อย แม้อยากจะชะลอการมีบุตร

วันคุมกําเนิดโลก ปี 55 ผลสำรวจชี้ หญิงเอเชียคุมกําเนิดน้อย แม้อยากจะชะลอการมีบุตรชาย-หญิงไทย คุมกำเนิดไม่ถูกวิธี เลือกหลั่งข้างนอก และกินยาคุมฉุกเฉิน ให้ผลไม่ 100% ผลงานวิจัย โดยไบเออร์ เฮลธ์แคร์ (Bayer HealthCare) พบ ชาย...

Sirtex Medical Limited: New Study of Primary Liver Cancer Seeks to Enroll 400 French Patients

'SARAH' a French national collaborative randomized controlled trial of radioembolization with yttrium-90 resin microspheres versus sorafenib in advanced hepatocellular carcinoma is now open for recruitment...

Medtronic and Bayer Diabetes Care Announce Alliance To Provide Blood Glucose Meter to Medtronic Patients Outside the United States

New Blood Glucose Meter to Provide Advanced Therapy Options for People with Diabetes Beginning in Canada and Europe Medtronic, Inc. (NYSE: MDT) and Bayer Diabetes Care, a...